Getinge AB
F:GTN

Watchlist Manager
Getinge AB Logo
Getinge AB
F:GTN
Watchlist
Price: 17.275 EUR -0.32% Market Closed
Market Cap: €4.4B

Wall St Price Targets

GTN Price Targets Summary
Getinge AB

Wall Street analysts forecast GTN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GTN is 24.942 EUR with a low forecast of 21.989 EUR and a high forecast of 30.108 EUR.

Lowest Forecast
Price Target
21.989 EUR
27% Upside
Average Forecast
Price Target
24.942 EUR
44% Upside
Highest Forecast
Price Target
30.108 EUR
74% Upside
Getinge AB Competitors:
Price Targets
ENTX
Entera Bio Ltd
496% Upside
PMVP
PMV Pharmaceuticals Inc
289% Upside
ATC
Arctic Paper SA
76% Upside
VSCO
Victoria's Secret & Co
7% Upside

Revenue
Forecast

5% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.

Gross Profit
Forecast

5% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

6% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 10%.

Pre-Tax Income
Forecast

14% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 20%.

Net Income
Forecast

7% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GTN's stock price target?
Price Target
24.942 EUR

According to Wall Street analysts, the average 1-year price target for GTN is 24.942 EUR with a low forecast of 21.989 EUR and a high forecast of 30.108 EUR.

What is the Revenue forecast for Getinge AB?
Projected CAGR
3%

Over the last 9 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.

What is the Gross Profit forecast for Getinge AB?
Projected CAGR
6%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 6%.

What is the Operating Income forecast for Getinge AB?
Projected CAGR
10%

Over the last 9 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 10%.

What is the Pre-Tax Income forecast for Getinge AB?
Projected CAGR
20%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for Getinge AB?
Projected CAGR
22%

Over the last 9 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett